Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Insider Favorites For Growth In March 2025

In This Article:

As of March 2025, the U.S. stock market has been experiencing a mixed performance, with major indices like the S&P 500 and Nasdaq posting their third straight weekly declines despite a recent rebound following positive comments from Federal Reserve Chair Jerome Powell. Amidst this backdrop of volatility and economic uncertainty, growth companies with high insider ownership can offer unique insights into potential investment opportunities, as insiders often have a deeper understanding of their company's prospects and are more likely to invest in businesses they believe will succeed.

Top 10 Growth Companies With High Insider Ownership In The United States

Name

Insider Ownership

Earnings Growth

Atour Lifestyle Holdings (NasdaqGS:ATAT)

26%

25.6%

Duolingo (NasdaqGS:DUOL)

14.4%

37%

Hims & Hers Health (NYSE:HIMS)

13.2%

21.9%

Corcept Therapeutics (NasdaqCM:CORT)

11.7%

36.7%

Kingstone Companies (NasdaqCM:KINS)

17.9%

24.2%

Astera Labs (NasdaqGS:ALAB)

15.9%

61.1%

BBB Foods (NYSE:TBBB)

16.5%

41.1%

Clene (NasdaqCM:CLNN)

20.7%

59.1%

Upstart Holdings (NasdaqGS:UPST)

12.7%

100.1%

Credit Acceptance (NasdaqGS:CACC)

14.4%

33.6%

Click here to see the full list of 205 stocks from our Fast Growing US Companies With High Insider Ownership screener.

Underneath we present a selection of stocks filtered out by our screen.

Astrana Health

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Astrana Health, Inc. is a physician-centric technology-powered healthcare management company providing medical care services in the United States, with a market cap of approximately $1.41 billion.

Operations: Astrana Health generates revenue through its segments: Care Delivery ($136.67 million), Care Partners ($1.95 billion), and Care Enablement ($155.45 million).

Insider Ownership: 13.2%

Astrana Health's revenue is forecast to grow at 18% annually, outpacing the US market. Despite a recent net loss in Q4 2024, annual earnings are expected to increase significantly over the next three years. The company trades below its estimated fair value and anticipates revenue up to US$2.7 billion in 2025. Recent financial activities include a substantial credit agreement for acquisitions and a share repurchase program, although insider trading data is unavailable.

NasdaqCM:ASTH Earnings and Revenue Growth as at Mar 2025
NasdaqCM:ASTH Earnings and Revenue Growth as at Mar 2025

Afya

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Afya Limited is a medical education group operating in Brazil with a market cap of approximately $1.55 billion.